28A2 Waldman, Scott - Thomas Jefferson University - Thomas Jefferson University

Scott A. Waldman, MD, PhD

Contact Dr. Waldman

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-6086
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C
  2. Managing the innovation supply chain to maximize personalized medicine
  3. Antiobesity pharmacotherapy: New drugs and emerging targets
  4. Policies to aid the adoption of personalized medicine
  5. Molecular insights provide the critical path to disease mitigation
  6. Erratum: Cardiopoietic stem cell therapy in heart failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter randomized trial with lineage-specified biologics (Journal of the American College of Cardiology (2013) 61 (2329-2338))
  7. Genetics and genomics for the prevention and treatment of cardiovascular disease: Update a scientific statement from the american heart association
  8. Reply: The C-CURE randomized clinical trial (Cardiopoietic stem Cell therapy in heart failURE)
  9. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer
  10. Advances in cancer immunotherapy
  11. Colorectal cancer immunotherapy
  12. Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis
  13. Evidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer: Lessons learned from the us armed forces: Consensus and future directions
  14. Molecular staging of node negative patients with colorectal cancer
  15. Systems approaches evolve clinical pharmacology
  16. Cardiopoietic stem cell therapy in heart failure: The C-CURE (cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics
  17. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: A novel application in pediatric nanomedicine
  18. New advances in models and strategies for developing anti-obesity drugs
  19. Colorectal cancer stem cells as biomarkers: Where it all starts?
  20. Systems-based discovery advances drug development